Download PDF
Synthesis 2017; 49(19): 4517-4522
DOI: 10.1055/s-0036-1588498
paper
© Georg Thieme Verlag Stuttgart · New York

Convenient Synthesis of Oxazolo[5,4-h]pyrrolo[4,3,2-de]quino­lones via Hypervalent Iodine Mediated Intramolecular Oxidative Cyclization

Chun-Meng Wang
Jiangsu Key Laboratory of Drug Design & Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, P. R. of China   Email: chslp@cpu.edu.cn
,
Sheng-Wei Yang
Jiangsu Key Laboratory of Drug Design & Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, P. R. of China   Email: chslp@cpu.edu.cn
,
Kai-Xiang Tang
Jiangsu Key Laboratory of Drug Design & Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, P. R. of China   Email: chslp@cpu.edu.cn
,
Tian-Hong Gao
Jiangsu Key Laboratory of Drug Design & Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, P. R. of China   Email: chslp@cpu.edu.cn
,
Bo Pang
Jiangsu Key Laboratory of Drug Design & Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, P. R. of China   Email: chslp@cpu.edu.cn
,
Yu-Ting Chen
Jiangsu Key Laboratory of Drug Design & Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, P. R. of China   Email: chslp@cpu.edu.cn
,
Jing Wu
Jiangsu Key Laboratory of Drug Design & Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, P. R. of China   Email: chslp@cpu.edu.cn
,
Jia Liu
Jiangsu Key Laboratory of Drug Design & Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, P. R. of China   Email: chslp@cpu.edu.cn
,
Yu-Fan Shi
Jiangsu Key Laboratory of Drug Design & Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, P. R. of China   Email: chslp@cpu.edu.cn
,
Li-Ping Sun*
Jiangsu Key Laboratory of Drug Design & Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, P. R. of China   Email: chslp@cpu.edu.cn
› Author AffiliationsWe are grateful for the funds supported by the National Natural Science Foundation (No. 21472243), the Qing Lan Project in Jiangsu Province, and the National College Students Innovation Training Program.
Further Information

Publication History

Received: 20 March 2017

Accepted after revision: 16 June 2017

Publication Date:
19 July 2017 (online)

    Permissions and Reprints All articles of this category


Abstract

A convenient and practical method has been developed for the synthesis of substituted oxazolo[5,4-h]pyrrolo[4,3,2-de]quinolones via the intramolecular oxidative cyclization by using PIFA as oxidant and TMSOTf as additive in DCE under an air atmosphere. The reaction proceeds in good yields and has good functional groups tolerance.

Key words

intramolecular - PIFA - oxidative cyclization - C–O formation - pyrrolo[4,3,2-de]quinolone

Supporting Information

    Supporting information for this article is available online at https://doi.org/10.1055/s-0036-1588498.
  • Supporting Information
 

  • References

    • 1a Moiinski TF. Chem. Rev. 1993; 93: 1825
      Crossref
    • 1b Hughes CC. MacMillan JB. Gaudencio SP. Jensen PR. Fenical W. Angew. Chem. Int. Ed. 2009; 48: 725
      CrossrefPubMed
    • 1c Miyanaga A. Janso JE. McDonald L. He M. Liu H. Barbieri L. Eustaquio AS. Fielding EN. Carter GT. Jensen PR. Feng X. Leighton M. Koehn FE. Moore BS. J. Am. Chem. Soc. 2011; 133: 13311
      CrossrefPubMed
  • 2 Yang S.-W. Wang C.-M. Tang K.-X. Wang J.-X. Sun L.-P. Eur. J. Org. Chem 2016; 1050
    • 3a Wang XQ. Sarris K. Kage K. Zhang D. Brown SP. Kolasa T. Surowy C. Elkouhen OF. Muchmore SW. Brioni JD. Stewart AO. J. Med. Chem. 2009;  52: 170
      CrossrefPubMed
    • 3b Senger J. Melesina J. Marek M. Romier C. Oehme I. Witt O. Sippl W. Jung M. J. Med. Chem. 2016;  59: 1545
      CrossrefPubMed
    • 3c Admi V. Afek U. Carmeli S. J. Nat. Prod. 1996;  59: 396
      Crossref
    • 4a Ben-Alloum A. Bakkas S. Soufiaoui M. Tetrahedron Lett. 1997; 38: 6395
      Crossref
    • 4b Malamas MS. Manas ES. McDevitt RE. Gunawan I. Xu Z.-B. Collini MD. Miller CP. Dinh T. Henderson RA. Keith JC. Harris HA. J. Med. Chem. 2004; 47: 5021
      Crossref
    • 4c Hein DW. Alheim RJ. Leavitt JJ. J. Am. Chem. Soc. 1957; 79: 427
      Crossref
    • 5a Evindar G. Batey RA. J. Org. Chem. 2006; 71: 1802
      Crossref
    • 5b Viirre RD. Evindar G. Batey RA. J. Org. Chem. 2008; 73: 3452
      Crossref
    • 5c Bonnamour J. Bolm C. Org. Lett. 2008; 10: 2665
      CrossrefPubMed
    • 6a Ueda S. Nagasawa H. Angew. Chem. Int. Ed. 2008; 47: 6411
      Crossref
    • 6b Ueda S. Nagasawa H. J. Org. Chem. 2009; 74: 4272
      Crossref
  • 7 Wang H. Wang L. Shang J. Li X. Wang H. Gui J. Lei A. Chem. Commun. 2012; 48: 76
    CrossrefPubMed
    • 9a Bose DS. Idrees M. Tetrahedron Lett. 2007; 48: 669
      Crossref
    • 9b Bose DS. Idrees M. J. Org. Chem. 2006; 71: 8261
      CrossrefPubMed
    • 9c Downer-Riley NK. Jackson YA. Tetrahedron 2008; 64: 7741
      Crossref
    • 9d Alla SK. Sadhu P. Punniyamurthy T. J. Org. Chem. 2014; 79: 7502
      Crossref
    • 9e Yu W. Yu Z. Ma L. Synlett 2012; 23: 1534
      Article in Thieme Connect
    • 9f Zheng Y.-H. Li X.-M. Ren C.-F. Zhang-Negrerie D. Du Y.-F. Zhao K. J. Org. Chem. 2012; 77: 10353
      Crossref

      For examples, see:
    • 10a Shi L. Kim Y.-J. Gin DY. J. Am. Chem. Soc. 2001; 123: 6939
      CrossrefPubMed
    • 10b Itoh N. Sakamoto T. Miyazawa E. Kikugawa Y. J. Org. Chem. 2002; 67: 7424
      Crossref